Attendees voted with their RESI Cash alongside judges’ scores to determine this year’s winners.
By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN
Life Science Nation is pleased to announce the investor panelists for RESI JPM 2026, taking place January 12–13 during JPM Healthcare Week. Across two full days, RESI JPM will bring together active investors, strategic partners, and industry leaders for focused discussions on the funding environment, partnership strategies, and emerging opportunities across life sciences and healthcare.
RESI investor panels are designed to provide founders and executives with direct insight from decision-makers who are actively deploying capital, forming partnerships, and shaping the future of the industry. Each panel features experienced investors and strategics sharing candid perspectives, followed by opportunities to continue conversations through RESI’s structured partnering platform.
Investor Speakers on Day 1 (January 12)
 Sharon Chan Johnson & Johnson Innovation – JLABS Asia Pacific |
 Irene Cheong A*STAR |
 Ansbert Gadicke MPM BioImpact |
 Dushyant Pathak Autobahn Labs |
 Andrew Krowne Dolby Family Ventures |
 Robert Balfour ALSA Ventures |
 Rick Berenson Mass Medical Angels |
 Gunes Bozkurt Beiersdorf |
 Jian Cao Medtronic |
 Jeff Chu Features Capital |
 Karen Chu Harvest Integrated Research Organization (HiRO) |
 Rod Cotton 2Flo Ventures |
 Juan Cueva Johnson & Johnson Innovation |
 Bettina Ernst BERNINA BioInvest |
 Jack Florio NuFund Venture Group |
 Nirdesh Gupta Cedars-Sinai Technology Ventures |
 Karen Harris Alzheimers Drug Discovery Foundation |
 Uplaksh Kumar Foresite Capital |
 Ken Lin ABIES Capital |
 Michael Loftus PoC Capital |
 Brianna McDonald Ecosystem Venture Group |
 Swati Mehta 25BIO |
 Ahmed Mousa LAFANA |
 Mahesh Narayanan Neuvation Ventures |
 Kenny Nova Mid Atlantic Bio Angels |
 Jessica Owens INITIATE Ventures |
 Jojo Platt Corundum Neuroscience |
 Steven Saltzstein FORCE Family Office |
 Garth Smith Ontario Brain Institute |
 James Spann Boyd Street Ventures |
 Jessica Tam Baxter Healthcare |
 Lee Chuan Teck Enterprise Singapore |
 Varun Turlapati Chaanakya Capital |
Investor Speakers on Day 2 (January 13)
 Friedemann Janus Bayer |
 Jiaping Gu Takeda Ventures |
 David Berry Averin Capital |
 Ekaterine Kortkhonjia Johnson & Johnson Innovation |
 Nick Naclerio Illumina Ventures |
 Eric Schaefer March of Dimes |
 Marc Appel Pacific Bridge NY |
 Anjan Aralihalli Raya Therapeutic |
 Yaron Daniely aMoon Fund |
 Miriam Dong ID3 Ventures |
 Cristina Escoda Tachyon Ventures |
 Yinghong Gao Viva BioInnovator |
 Gary Gershony BayMed Venture Partners |
 Tom Gibbs Debiopharm Innovation Fund |
 Rohit Jain HBS Alumni Angels of Northern California |
 Sai Jasti Bayer |
 Anula Jayasuriya Kidron Capital |
 Gautam Kainth TCP Health Ventures |
 Jin Lee Oxonian Ventures |
 Brian Miglionico Agios Pharmaceuticals |
 Ralph Morales III Aquillius Ventures |
 Stephanie Oestreich Myeloma Investment Fund |
 Donna Parr Cross-Border Impact Ventures |
 Bibi Sattar Marques Buenavista Equity Partners |
 Takehiko Sawabe Beyond Next Ventures |
 Venkat Srinivasan Innospark Ventures |
 Anthony Vallance-Owen We Venture Capital |
 Chensu Wang Yonjin Venture |
 Chris Yoo Xcellerant Ventures |
 Qing Zhang LDV Partners |
Register for RESI JPM 2026
RESI JPM 2026 offers more than panels. Attendees gain access to curated investor meetings through RESI’s partnering system, targeted networking, and programming designed to support meaningful connections during one of the most important weeks in healthcare investment.
| Register for RESI JPM 2026 |
Next Phase Newsletter 
Leave a comment